Joint statement from the GPhC and RPS on the safety features under the Falsified Medicines Directive coming into force

Joint statement from the General Pharmaceutical Council and Royal Pharmaceutical Society on the safety features under the Falsified Medicines Directive coming into force

The legal requirements of the safety features Delegated Regulation under the Falsified Medicines Directive (FMD) will be in force from 9 February 2019 onwards. 

The chief executives of the GPhC and RPS met earlier this week to discuss professional concerns around FMD implementation.

Duncan Rudkin, Chief Executive of the General Pharmaceutical Council, said:

 “We recognise that not all pharmacies will be meeting the legal obligations of FMD straight away.  We intend to take a pragmatic and proportionate approach to the implementation of the new safety features.  When inspecting a pharmacy, our inspectors would consider all of the relevant evidence, including whether the pharmacy had a clear plan in place to meet all of the requirements of FMD, before deciding whether or not the relevant standard had been met.”

Paul Bennett, Chief Executive of the RPS, said:

“We welcome the pragmatic approach taken by the GPhC in relation to FMD, which we hope will provide some assurance to our members in pharmacies that are still working towards meeting all of the requirements relating to FMD.  The RPS has produced a guide to FMD to support members and we are also here to answer any queries that members have.”

Please also see our joint statement with the MHRA on FMD.